Publications by authors named "John W Longshore"

12Publications

Comprehensive Molecular Testing Functions Best in a Consolidated Model.

Authors:
John W Longshore

Clin Chem 2019 Nov 12. Epub 2019 Nov 12.

Carolinas Pathology Group, Atrium Health Core Laboratory, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2019.304626DOI Listing
November 2019

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

J Clin Oncol 2017 Dec 20;35(34):3867-3876. Epub 2017 Oct 20.

Reinhard Büttner, University Hospital Cologne, Cologne; Manfred Dietel, Charité Universitätsmedizin Berlin, Berlin, Germany; John R. Gosney, Royal Liverpool University Hospital, Liverpool; Andrew C. Wotherspoon, Royal Marsden Hospital, London; Keith M. Kerr, Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom; Birgit Guldhammer Skov, Copenhagen University Hospital, Copenhagen, Denmark; Julien Adam, Gustave Roussy Cancer Center, Villejuif; Frédérique Penault-Llorca, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France; Noriko Motoi, National Cancer Center Hospital, Tokyo, Japan; Kenneth J. Bloom, Human Longevity, San Diego, CA; John W. Longshore, Carolinas Pathology Group, Charlotte, NC; Fernando López-Ríos, Hospital Universitario HM Sanchinarro, Madrid, Spain; Giuseppe Viale, University of Milan, Milan, Italy; and Ming-Sound Tsao, University Health Network, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.7642DOI Listing
December 2017

The evolution of routine PCR testing: insights from the core lab model.

Authors:
John W Longshore

MLO Med Lab Obs 2015 Nov;47(11):22-3

View Article

Download full-text PDF

Source
November 2015

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Oncologist 2015 Oct 1;20(10):1175-81. Epub 2015 Sep 1.

Mount Sinai Health Systems, New York, New York, USA; Pfizer Oncology, New York, New York, USA; Cone Health Cancer Center, Greensboro, North Carolina, USA; Carolinas Pathology Group, Carolinas HealthCare System, Charlotte, North Carolina, USA; Chao Family Comprehensive Cancer Center, University of California at Irvine School of Medicine, Orange, California, USA; US Oncology Research, Ocala, Florida, USA; Carolinas HealthCare System, Charlotte, North Carolina, USA; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; University of Colorado Cancer Center, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591939PMC
October 2015

BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply.

Hum Pathol 2015 Jul 11;46(7):1065-6. Epub 2015 Apr 11.

Carolinas Pathology Group, Charlotte, NC 28203.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2015.03.011DOI Listing
July 2015

A retrospective analysis of the clinical performance of human papillomavirus testing using SurePath sample collection.

J Am Soc Cytopathol 2014 May - Jun;3(3):165-169. Epub 2014 Feb 23.

Department of Pathology, Carolinas Pathology Group, Carolinas HealthCare System, 1000 Blythe Boulevard, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22132945140007
Publisher Site
http://dx.doi.org/10.1016/j.jasc.2014.02.002DOI Listing
February 2014